PV Bulletin

Proposed Regulation for Complementary Health Products in Singapore

HSA invites feedback on new regulatory framework for Complementary Health Products (CHP) under the Health Products Act.

Primary source: Health Sciences Authority

PV Impact Brief

Urgency: HighConfidence: high

What changed

New mandatory safety reporting and record-keeping requirements for suppliers of Complementary Health Products (CHPs) in Singapore are proposed under the Health Products Act.

Why it matters

These requirements will strengthen the oversight of CHP products, ensuring better safety and quality standards which could impact compliance workflows for suppliers.

Action needed

Suppliers must implement new protocols for safety reporting and record-keeping as per the proposed framework.

Relevant for
Regulatory Intelligence LeadSignal Management LeadQPPV
Processes impacted
Country ComplianceSignal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review before 2026-07-29.

Policy change details

Document type
Consultation
Policy status
consultation
Publication date
2026-07-01
Consultation deadline
2026-07-29
Policy change
HSA invites feedback on a proposed regulatory framework for Complementary Health Products (CHP) under the Health Products Act, aimed at strengthening oversight of product safety, quality, and duties of suppliers.

Key changes

Proposed requirements for Product Notification, Record Keeping, and Safety Reporting for CHPs.

Affected workflows

Country ComplianceSignal Management

PV impact

Suppliers of CHPs in Singapore may face new mandatory safety reporting and record-keeping requirements under the proposed framework.

View regulator source

Source document details

Unable to extract linked source document: https://www.googletagmanager.com/ns.html

Evidence and confidence

Confidence: highSource updated: Jul 1, 2026

Full briefing

Practical implication

Suppliers must implement new protocols for safety reporting and record-keeping as per the proposed framework.

The Health Sciences Authority (HSA) of Singapore has opened a consultation on a proposed regulatory framework aimed at enhancing the safety and quality oversight of Complementary Health Products (CHP). This includes new mandatory requirements for Product Notification, Record Keeping, and Safety Reporting. The deadline for feedback is July 29, 2026.

What changed: New mandatory safety reporting and record-keeping requirements for suppliers of Complementary Health Products (CHPs) in Singapore are proposed under the Health Products Act.

Why it matters: These requirements will strengthen the oversight of CHP products, ensuring better safety and quality standards which could impact compliance workflows for suppliers.

Practical implication: Suppliers must implement new protocols for safety reporting and record-keeping as per the proposed framework.

View original source

Published from the Firecrawl policy change extraction pipeline.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward